1007-3639
2006 Issue 7
xiao chang xi mo xian wei liu bing ban you shen ji shui 1 li
wang kang ; li si guang
wang kang ; li si guang
..............page:604
ru xian ai zhi liao hou fa sheng ban you t(4;11) he mll zhong pai de ji xing qian b lin ba xi bao bai xue bing --1 li bao gao fu wen xian fu xi
chen qin fen ; li pei ; zhu ping ; wu zuo zuo ; wang wei ; xie yi
chen qin fen ; li pei ; zhu ping ; wu zuo zuo ; wang wei ; xie yi
..............page:602-603
Advances in research of MAGE-A3
LI Hao;LIU Bing-ya
LI Hao;LIU Bing-ya
..............page:599-601
Expression of cyclooxygenase-2 and its clinicopathologic and prognostic significance in endometrial cancer
SUN Zhi;WANG Hua-ying
SUN Zhi;WANG Hua-ying
..............page:594-598
Diagnosis, treatments and prognosis of local recurrence of breast cancer after conservative therapy
YU Ke-da;SHAO Zhi-min
YU Ke-da;SHAO Zhi-min
..............page:589-593
Progression and study of the catalytic subunit of human telomerase (hTERT) in tumor therapy
SHEN Ying;ZHANG Yong-wei;DING Jian
SHEN Ying;ZHANG Yong-wei;DING Jian
..............page:584-588
Whole body hyperthermia combined with FOLFOX regimen in the treatment of 21 cases of advanced gastric cancer
ZHENG Hong;LI Yong;FANG Ding-zhu;CHEN Shi-wei;SHI Yi;XU Feng;WANG Hai-ping
ZHENG Hong;LI Yong;FANG Ding-zhu;CHEN Shi-wei;SHI Yi;XU Feng;WANG Hai-ping
..............page:581-583
Studies of matrix metalloproteinase-9 and matrix metalloproteinase-2 expression in multiple myeloma patients
HUANG Zhong-xia;JI Feng-qing;CHEN Shi-lun;SUN Hai-mei;LIU Jin-wei;GUO Yi-qun;ZHANG Lei;CHEN Wen-ming;DAI Hong
HUANG Zhong-xia;JI Feng-qing;CHEN Shi-lun;SUN Hai-mei;LIU Jin-wei;GUO Yi-qun;ZHANG Lei;CHEN Wen-ming;DAI Hong
..............page:578-580
Clinical study of Fludarabine-based combination chemotherapy for non-Hodgkin lymphoma patients
CAO Jun-ning;YIN Ji-liang;WANG Jia-lei;HU Xi-chun;ZHU Xiao-dong;HONG Xiao-nan
CAO Jun-ning;YIN Ji-liang;WANG Jia-lei;HU Xi-chun;ZHU Xiao-dong;HONG Xiao-nan
..............page:575-577
An analysis of 248 cycles of moderate dose cytarabine for acute myeloid leukemia-outcome and side effects
HAN Jie-ying;CHEN Fang-yuan;WANG Ting;ZHONG Lu;HU Xiao-fei;XU Lan;OU YANG Ren-rong
HAN Jie-ying;CHEN Fang-yuan;WANG Ting;ZHONG Lu;HU Xiao-fei;XU Lan;OU YANG Ren-rong
..............page:572-574
An analysis of continuous conventional fractionated radiotherapy (CCFRT) for nasopharyngeal carcinoma
WANG Yi-ming;FU Qiang;LIN Shao-ming;KONG Fei;CHEN Xian-zhao;TANG Qi-xin
WANG Yi-ming;FU Qiang;LIN Shao-ming;KONG Fei;CHEN Xian-zhao;TANG Qi-xin
..............page:568-571
Detection of bone marrow involvement using flow cytometry in B cell lymphoma
CHEN Zhi-yu;ZHOU Xiao-yan;WENG Xiang-qin;SHI Da-ren
CHEN Zhi-yu;ZHOU Xiao-yan;WENG Xiang-qin;SHI Da-ren
..............page:562-567
The expressions of COX-2 and VEGF-C in stage Ⅱ and Ⅲ rectal cancer and its association with angiogenesis and prognoses
WANG Ming-he;SHI Ying-qiang;LU Hong-fen
WANG Ming-he;SHI Ying-qiang;LU Hong-fen
..............page:557-561,567
Influence of survivin gene RNA interference on cell apoptosis and the sensitivity to cisplatin in cervical cancer cell HeLa
SONG Hui;XIN Xiao-yan;XIAO Feng;WANG De-tang;HAN Xing;GUO Hui-ling
SONG Hui;XIN Xiao-yan;XIAO Feng;WANG De-tang;HAN Xing;GUO Hui-ling
..............page:551-556
Study on the expression of PTEN and P53 in human primary gallbladder carcinoma(HGC)
HUANG Ying;ZHENG Chang-li
HUANG Ying;ZHENG Chang-li
..............page:547-550
The study on the expression of HIF-1α and its association with the expression of HER-2 and survivin in breast carcinoma
YUAN Xiang-lin;YU Shi-ying;XIA Shu
YUAN Xiang-lin;YU Shi-ying;XIA Shu
..............page:544-546
The Effects of rhG-CSF on morphology,phenotype and function of neutrophil in patients with malignant lymphoma after the treatment of chemotherapy
ZHONG Ji-hua;HUANG Hong-hui;CHEN Fang-yuan;HAN Jie-ying;OU YANG Ren-rong
ZHONG Ji-hua;HUANG Hong-hui;CHEN Fang-yuan;HAN Jie-ying;OU YANG Ren-rong
..............page:540-543
Expression of fasciclin and annexin I in the pre-malignant lesions of esophageal squamous cell carcinoma
HUANG Ying-feng;ZHAO Xiao-hang;WANG Gui-qi;LIU Fang;ZHOU Lan-ping
HUANG Ying-feng;ZHAO Xiao-hang;WANG Gui-qi;LIU Fang;ZHOU Lan-ping
..............page:536-539
The impact of arresten on proliferation of huvec cells and its mechanism
LONG Miao-yun;ZHENG Qi-chang;SONG Zi-fang;HU Qing-gang;ZHANG Yong
LONG Miao-yun;ZHENG Qi-chang;SONG Zi-fang;HU Qing-gang;ZHANG Yong
..............page:533-535
The impact of DOC-2 expression on the tumorigenesis of human ovarian cancer cell line(HO-8910)
LIU Shu-juan;HAN Jun-tao;XIN Xiao-yan;CHEN Bi-liang
LIU Shu-juan;HAN Jun-tao;XIN Xiao-yan;CHEN Bi-liang
..............page:530-532
A meta-analysis of cyclin E and its impact on the prognosis of breast cancer patients
WANG Lei;FAN Jiang;WANG Xiao-jin;DI Gen-hong;SHEN Zhen-zhou;SHAO Zhi-min
WANG Lei;FAN Jiang;WANG Xiao-jin;DI Gen-hong;SHEN Zhen-zhou;SHAO Zhi-min
..............page:525-529